Hudson Bay Capital Management LP Enanta Pharmaceuticals Inc Transaction History

Hudson Bay Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$60.19 - $97.37 $1.5 Million - $2.43 Million	-25,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$41.02 - $58.65 $2.05 Million - $2.93 Million	-50,000 Reduced 66.67%	25,000 $1.42 Million
Q2 2021 Aug 16, 2021	BUY	$43.76 - $53.11 $875,200 - $1.06 Million	20,000 Added 36.36%	75,000 $3.3 Million
Q1 2021 May 14, 2021	SELL	$41.69 - $54.95 $400,224 - $527,520	-9,600 Reduced 14.86%	55,000 $2.71 Million
Q4 2020 Feb 12, 2021	BUY	$41.16 - $47.47 $806,735 - $930,412	19,600 Added 43.56%	64,600 $2.72 Million
Q3 2020 Nov 12, 2020	BUY	$43.36 - $53.53 $1.75 Million - $2.15 Million	40,254 Added 848.17%	45,000 $2.06 Million
Q2 2020 Aug 12, 2020	BUY	$46.37 - $57.58 $220,072 - $273,274	4,746 New	4,746 $238,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $177M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.